Advancing Neuroscience: Breakthroughs in Biomarker Discovery and Preclinical Development for Neurological Diseases

You are invited to a complimentary neuroscience symposium in South San Francisco, CA. Hosted by BioIVT, home to the Center for NeuroExcellence, this symposium will bring together leading researchers, drug developers, and industry professionals to explore cutting-edge advancements in neuroscience and biomarkers.

Featuring researchers from academia, industry, and BioIVT, this event will highlight breakthroughs in biomarker discovery and preclinical drug development in neurological diseases.

Target Audience:

• Drug developers interested in the latest advancements in biomarkers for neurodegenerative diseases
• Scientists and directors interested in overcoming challenges for CNS-targeting drugs
• Lab scientists, managers, and directors in biotech/pharma working on drug development in CNS diseases

Attendees will learn:

The importance and application of biomarkers in neurodegenerative diseases, including how demographic factors influence biomarkers and the latest advances in blood biomarker tests.

The challenges of developing CNS drugs and crossing the blood-brain barrier, with a focus on the pivotal role of transporters.

The latest breakthroughs and innovative therapies in drug development for neurodegenerative diseases such as ALS and Alzheimer’s disease.

Cutting-edge research on Alzheimer’s disease, from uncovering key pathology drivers and biomarkers to advancing therapeutic innovation.

Registration is required to attend.